Insider trade

Director received an award of 218.61 AMGN shares

Traded Nov 7, 2025 · Filed Nov 13, 2025

AmgenAMGN

218.61
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 7, 2025
Reporting period: Not applicable
Filed with the SEC: Nov 13, 2025

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references dividend reinvestment

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000318154-25-000077
Filed / recorded

Nov 13, 2025, 12:31 AM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

AMGEN INC

Issuer CIK

318154

Ticker

AMGN

Reporting person

Michael V Drake

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Nov 7, 2025

Transaction code

A

Shares / units

218.6134

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

4,958.6425

Ownership form

Direct

Amendment

No

Footnotes from the filing

These shares include 268 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.